概括
有效的痴呆症管理优先考虑教育和非药物治疗. 虽然有一些药物存在,但它们的使用需要仔细考虑个体需求和证据,特别是对于像阿杜卡努马布这样的新疗法.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 痴呆症护理需要个性化的患者教育和现实的期望.
- 维生素和补充剂用于增强记忆力缺乏支持证据.
- 在所有痴呆症阶段,非药物干预措施至关重要.
研究的目的:
- 概述目前基于证据的痴呆症管理策略.
- 讨论药物治疗和非药物治疗在痴呆症护理中的作用.
- 为应对管理痴呆症行为和心理症状的挑战.
主要方法:
- 审查关于痴呆症药物治疗和非药物治疗的当前文献.
- 分析管理认知和行为症状的指导方针.
- 评估新的治疗方法,如阿杜卡努马布.
主要成果:
- 最初的药物治疗通常包括胆酶抑制剂和记忆剂,以患者特定的因素为指导.
- 非药物治疗是治疗行为和心理症状的主要方法.
- 像阿杜卡努马布这样的新疗法对认知益处的证据有限,并面临进入障碍.
结论:
- 痴呆症管理需要个性化的方法,平衡药物治疗和非药物治疗.
- 护理人员的投入和功能评估对于评估治疗疗效至关重要.
- 仔细考虑风险,益处和成本对于所有痴呆症治疗是必不可少的.
相关概念视频
Dementia
117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
117
Alzheimer's Disease: Overview
496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196
Methods of Documentation VI: Case Management Model
574
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
574
Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
Ethical Dilemmas II
1.1K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.1K


